Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 30, 577-595, March 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeBaun, J. R.
Right arrow Articles by Miller, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeBaun, J. R.
Right arrow Articles by Miller, J. A.

N-Hydroxy-2-acetylaminofluorene Sulfotransferase: Its Probable Role in Carcinogenesis and in Protein-(methion-S-yl) Binding in Rat Liver1

Jack R. DeBaun, Elizabeth C. Miller and James A. Miller

McArdle Laboratory for Cancer Research, University of Wisconsin Medical Center, Madison, Wisconsin 53706

1- and 3-Methylmercapto-2-acetylaminofluorene (1- and 3-methylmercapto-AAF) were identified as degradation products of hepatic protein-bound methionyl derivatives in rats given AAF or N-hydroxy-AAF. The same derivatives were shown previously to be products of the in vitro reaction of free or peptide-bound methionine with various synthetic esters of N-hydroxy-AAF, including the very reactive O-sulfonate (AAF-N-sulfate). The amounts of o-methylmercapto-AAF obtained from liver protein were proportional to the dose of N-hydroxy-AAF given i.p. and appear to be a measure of the amount of ester-like metabolites of the carcinogen formed in vivo. 1- and 3-Methylmercapto-2-aminofluorene were not obtained as degradation products of the liver proteins of rats or other animals given N-hydroxy-AAF or of rats given N-hydroxy-2-aminofluorene.

The soluble proteins of rat liver contain sulfotransferase(s) which synthesize AAF-N-sulfate from N-hydroxy-AAF and 3'-phosphoadenosine 5'-phosphosulfate; magnesium and manganous ions stimulate the system. Under a variety of conditions, the N-hydroxy-AAF sulfotransferase activity in rat liver, as assayed in vitro, paralleled the amounts of o-methylmercapto-AAF which could be released from the livers of similarly treated rats after administration of N-hydroxy-AAF and the susceptibility to liver tumor induction by N-hydroxy-AAF. Adult male rat liver, which is highly susceptible to carcinogenesis with N-hydroxy-AAF, contained considerably more N-hydroxy-AAF sulfotransferase activity and formed considerably more protein-bound 1- and 3-(methion-S-yl)-AAF in vivo than did the livers of female rats or of male mice, hamsters, rabbits, or guinea pigs. Female rats and the latter species are relatively resistant to hepatic carcinogenesis with N-hydroxy-AAF. Similarly, the increased hepatic carcinogenicity of 2-aminofluorene derivatives in female gonadectomized rats given testosterone and the marked inhibition of hepatocarcinogenesis with N-hydroxy-AAF in hypophysectomized or thyroidectomized male rats were mirrored by corresponding changes in hepatic sulfotransferase activity for N-hydroxy-AAF and the formation of protein-bound methionyl-AAF derivatives in vivo. The results strongly suggest that AAF-N-sulfate is at least one of the ultimate reactive and carcinogenic metabolites of AAF and N-hydroxy-AAF in rat liver.

Syntheses of the following new compounds are described: N-methoxy-AAF, potassium 4-acetylaminobiphenyl-N-sulfate, 3-methylmercapto-4-acetylaminophenyl, and 3-methylmercapto-4-aminobiphenyl hydrochloride.

1 This investigation was supported by Research Training Grant CRTY-5002 and Program-Project Grant CA-0175 of the National Cancer Institute, USPHS, and by grants from the Jane Coffin Childs Memorial Fund for Medical Research and the Alexander and Margaret Stewart Trust Fund.

Received 7/11/69. Accepted 8/11/69.




This article has been cited by other articles:


Home page
Int J EpidemiolHome page
G. Lower Jr, T Nilsson, C. Nelson, H Wolf, T. Gamsky, and G. Bryan
N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark
Int. J. Epidemiol., March 11, 2007; (2007) dyl290v1.
[Full Text] [PDF]


Home page
Toxicol SciHome page
Y. Alnouti and C. D. Klaassen
Tissue Distribution and Ontogeny of Sulfotransferase Enzymes in Mice
Toxicol. Sci., October 1, 2006; 93(2): 242 - 255.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. T. Dunn II, B. A. Gleason, D. P. Hartley, and C. D. Klaassen
Postnatal Ontogeny and Hormonal Regulation of Sulfotransferase SULT1B1 in Male and Female Rats
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 319 - 324.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Sakakibara, K. Yanagisawa, J. Katafuchi, D. P. Ringer, Y. Takami, T. Nakayama, M. Suiko, and M.-C. Liu
Molecular Cloning, Expression, and Characterization of Novel Human SULT1C Sulfotransferases That Catalyze the Sulfonation of N-Hydroxy-2-acetylaminofluorene
J. Biol. Chem., December 18, 1998; 273(51): 33929 - 33935.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. C. Kiehlbauch, Y. F. Lam, and D. P. Ringer
Homodimeric and Heterodimeric Aryl Sulfotransferases Catalyze the Sulfuric Acid Esterification of N-Hydroxy-2-acetylaminofluorene
J. Biol. Chem., August 11, 1995; 270(32): 18941 - 18947.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T Watabe, T Ishizuka, M Isobe, and N Ozawa
A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[alpha]anthracene
Science, January 22, 1982; 215(4531): 403 - 405.
[Abstract] [PDF]


Home page
ScienceHome page
J. Bakke, J. Gustafsson, and B. Gustafsson
Metabolism of propachlor by the germfree rat
Science, October 24, 1980; 210(4468): 433 - 435.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1970 by the American Association for Cancer Research.